Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mindfulness Through Adaptive Biofeedback in Anxiety Disorders
NCT07628153Phase 4Completed
- Sponsor
- Sechenov First Moscow State Medical University
- Start
- Jul 2022
- Primary completion
- Feb 2025
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial (3 arms), sponsored by Sechenov First Moscow State Medical University. Primary endpoints: Hamilton Anxiety Rating Scale total score at 1 month and Five Facet Mindfulness Questionnaire total score at 1 month. Started Jul 2022; status: completed.
Beyond the preview
Go deeper on NCT07628153.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07628153.